Positive New Data from Phase 1/2 Trial of AT-01 Presented :

AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac...

Related Keywords

Washington , United States , Luke Heagle , Amy Weisman , Attralus Inc , University Of Tennessee Research Foundation , American College Of Cardiology , University Of Tennessee Graduate School Medicine , Waltere Washington Convention Center , Cancer Theranostics Program , Tennessee Graduate School , American College , Annual Scientific Session , Poster Presentation , Cardiac Amyloidosis , Using Iodine Evuzamitide , Jonathan Wall , Distinguished Professor , Cancer Theranostics , Cardiac Imaging , Convention Center , Multimodality Imaging Moderated Poster Theater , Fully Automated , Amyloidophilic Radiotracer Iodine Evuzamitide , Systemic Amyloidosis , Multimodality Imaging , Poster Hall , Scientific Session , Tennessee Research , South San , Attralus , Nc , Amyloidosis , Iagnostic ,